Navigation Links
Reportlinker Adds Industrial Enzymes - A Global Market Report
Date:12/1/2009

ales in US$ Million)

Table 70: Percentage Breakdown of Industrial Enzymes Market

by End-Use Segment in Rest of Europe for the Years 2008 &

2012

Table 71: Percentage Breakdown of Leading Industrial Enzymes

Manufacturers in India - 2005

Table 72: Industrial Enzymes Market by Product Segment in

Asia-Pacific: 2007-2015 (Sales in US$ Million)

Table 73: Percentage Breakdown of Industrial Enzymes Market

by Product Segment in Asia-Pacific for the Years 2008 & 2012

Table 74: Industrial Enzymes Market by End-Use Segment in

Asia-Pacific: 2007-2015 (Sales in US$ Million)

Table 75: Percentage Breakdown of Industrial Enzymes Market by

End-Use Segment in Asia-Pacific for the Years 2008 & 2012

Table 76: Industrial Enzymes Market by Product Segment in

Middle East: 2007-2015 (Sales in US$ Million)

Table 77: Percentage Breakdown of Industrial Enzymes Market

by Product Segment in Middle East for the Years 2008 & 2012

Table 78: Industrial Enzymes Market by End-Use Segment in

Middle East: 2007-2015 (Sales in US$ Million)

Table 79: Percentage Breakdown of Industrial Enzymes Market by

End-Use Segment in Middle East for the Years 2008 & 2012

Table 80: Industrial Enzymes Market by Product Segment in

Latin America: 2007-2015 (Sales in US$ Million)

Table 81: Percentage Breakdown of Industrial Enzymes Market by

Product Segment in Latin America for the Years 2008 & 2012

Table 82: Industrial Enzymes Market by End-Use Segment in

Latin America: 2007-2015 (Sales in US$ Million)

Table 83: Percentage Breakdown of Industrial Enzymes Market by

End-Use Segment in Latin America for the Years 2008 & 2012

COMPANIES PROFILED

To order this repo
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment
2. Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013
3. Reportlinker Adds Biotechnology Reagents - A Global Market Perspective
4. Reportlinker Adds Bioinformatics - A Global Market Intelligence Report
5. Reportlinker Adds Diclofenac sodium (CAS 15307-79-6) Market Research Report 2009
6. Reportlinker Adds World Bioplastics Industry
7. Reportlinker Adds Cancer Vaccines: Measuring Market Potential
8. Reportlinker Adds Molecular Diagnostics: A Dynamic and Rapidly Broadening Market
9. Reportlinker Adds Worldwide Optical, Transmission TEM, and Scanning SEM Electron Microscope Market Shares, Strategies, and Forecasts, 2009 to 2015
10. Reportlinker Adds Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment
11. Reportlinker Adds Bioinformatics and Computational Biology: Bottlenecks and Options
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... May 30, 2015 The Cholangiocarcinoma ... research for bile duct cancer, announced today the ... Fellowship Program. , The Foundation has ... throughout the country to raise awareness about cholangiocarcinoma ... support research that opens new pathways for diagnosis ...
(Date:5/30/2015)... 2015 CTI BioPharma Corp. (CTI BioPharma) (NASDAQ ... BAX ) today announced data from PERSIST-1 – ... the treatment of myelofibrosis – in a late-breaking oral ... American Society of Clinical Oncology (ASCO), May 29-June 2, ... is an investigational oral multikinase inhibitor with specificity for ...
(Date:5/30/2015)... and RARITAN, N.J. , ... multi-center, open-label, two-part, single-arm Phase 2 MMY2002 (SIRIUS) ... investigational, human anti-CD38 monoclonal antibody – achieved an ... CI, 20.8-38.9), as assessed by an independent review ... The ORR was consistent among the pre-specified subgroups ...
(Date:5/30/2015)... May 30, 2015  Caris Life Sciences® today ... in which researchers identified biomarker changes, including key ... tumors, indicating changes in response to therapy as ... was a subset of a larger study analyzing ... the cancer. These data utilizing Caris Molecular Intelligence®, ...
Breaking Biology Technology:The Cholangiocarcinoma Foundation Awards $260,000 in Research Grants 2The Cholangiocarcinoma Foundation Awards $260,000 in Research Grants 3Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 2Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 3Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 4Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 5Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 6Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 7Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 8Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 9Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 10Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 2Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 3Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 4Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 5Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 6Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 7Caris Life Sciences Paired Tumor Data Identifies Key Driver Mutations and Confirms Tumor Heterogeneity in High-Grade Glioma Samples 2Caris Life Sciences Paired Tumor Data Identifies Key Driver Mutations and Confirms Tumor Heterogeneity in High-Grade Glioma Samples 3Caris Life Sciences Paired Tumor Data Identifies Key Driver Mutations and Confirms Tumor Heterogeneity in High-Grade Glioma Samples 4
... 2009 Waukesha Electric Systems, SuperPower, University of Houston, Oak ... in a $10.7 million smart grid demonstration project award ... on November 24. The funds will be used to ... the reliability of the nation,s power grid. , ...
... 22 /PRNewswire/ - Viron Therapeutics Inc., a biotechnology company ... that it has been granted U.S. patents related to ... These patents join a portfolio of more than 80 ... drug discovery platform identifies proteins expressed by non-human viruses ...
... , , , , SEATTLE, Dec. 22 ... announced today its support of the Pharmaceutical Research Manufacturers ... revised July 2008" (PhRMA Code). Adherence to the ... , "As CTI prepares for the potential launch ...
Cached Biology Technology:Waukesha Electric partners with SuperPower and UH to build fault current limiting superconducting transformer for Dept. of Energy 2Waukesha Electric partners with SuperPower and UH to build fault current limiting superconducting transformer for Dept. of Energy 3Viron granted U.S. Patents for Organ Transplant and Arthritis Drug Candidates 2Viron granted U.S. Patents for Organ Transplant and Arthritis Drug Candidates 3Cell Therapeutics Commits to PhRMA's Code on Interactions With Healthcare Professionals 2Cell Therapeutics Commits to PhRMA's Code on Interactions With Healthcare Professionals 3Cell Therapeutics Commits to PhRMA's Code on Interactions With Healthcare Professionals 4
(Date:5/29/2015)... May 28, 2015 Research and Markets ... the "Facial Recognition Market by Solution, by ... Forecast to 2020" report to their offering. ... facial recognition technology become more efficient and cost ... traction and investment from the commercial sector. The ...
(Date:5/28/2015)... 28, 2015 Industry analyst firm n-tech ... report titled "Markets for Self-Healing Materials: 2015-2022." According to ... and vascular systems, biomaterials, relevant shape memory materials ... $2.7 billion by 2020. The report ... of smart materials. Other recent n-tech reports have included ...
(Date:5/27/2015)...   Codonics (codonics.com), a global ... documentation solutions and Omnicell  (omnicell.com), a ... is pleased to announce their state of ... System® (SLS), an award-winning FDA class 2 ... Anesthesia Workstation, helps prevent medication errors, streamlines ...
Breaking Biology News(10 mins):Global advanced Facial Recognition Market Expected to Grow From $2.77 Billion in 2015 to $6.19 Billion in 2020, at an Estimated CAGR of 17.4% 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 3Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4
... contact the Communications and External Relations staff member identified at the ... research and development activities, please refer to one of our Media ... can send it to news@ornl.gov . ... recovering from injuries, the elderly and even athletes could one day ...
... CHAMPAIGN, lll. A protein that helps pack DNA into ... activity, scientists report. The researchers found that the protein, histone ... cellular workbenches on which all proteins are made. The ... Cell Biology . A human cell,s genetic material is ...
... occurrence of fishes in the ocean,s deepest reachesthe hadal zone, ... are more numerous at such depths than experts had thought. ... July/August issue of BioScience , observed 10 to 20 ... baited video lander in the Japan Trench. The observation period ...
Cached Biology News:Story tips from the Department of Energy's Oak Ridge National Laboratory July 2010 2Story tips from the Department of Energy's Oak Ridge National Laboratory July 2010 3Histone H1 regulates gene activity throughout the cell cycle 2Histone H1 regulates gene activity throughout the cell cycle 3Study suggests more fish than thought may thrive in the ocean's depths 2
... Rotor for use in the ... and Centra-MP4/MP4R. Perfect for ... and other difficult to separate ... containment. Complete with rotor and ...
Buckets for 2 racks of 5 tubes, type Stago/Hitachi...
Buckets for tube holder inserts...
Rotor for four tube-loaded buckets; ma RCF 2550g; sold without buckets...
Biology Products: